Drugs that contain Epinephrine
1. Adrenaclick patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5665071 | IMPAX | Reloadable automatic or manual emergency injection system |
May, 2013
(10 years ago) | |
| US10166344 | IMPAX | Injection needle assembly |
Jan, 2025
(8 months from now) | |
| US10166334 | IMPAX | Medicine injection apparatuses |
Jan, 2025
(8 months from now) | |
| US7905352 | IMPAX | Kits containing medicine injection devices and containers |
Apr, 2027
(2 years from now) | |
Market Authorisation Date: 25 November, 2009
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
ADRENACLICK family patents
2. Adrenalin patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9119876 | PAR STERILE PRODUCTS | Epinephrine formulations |
Mar, 2035
(10 years from now) | |
| US9295657 | PAR STERILE PRODUCTS | Epinephrine formulations |
Mar, 2035
(10 years from now) | |
| US10130592 | PAR STERILE PRODUCTS | Epinephrine formulations |
Mar, 2035
(10 years from now) | |
| US10653646 | PAR STERILE PRODUCTS | Epinephrine compositions and containers |
Mar, 2039
(14 years from now) | |
| US11083698 | PAR STERILE PRODUCTS | Epinephrine compositions and containers |
Mar, 2039
(14 years from now) | |
| US11207280 | PAR STERILE PRODUCTS | Epinephrine compositions and containers |
Mar, 2039
(14 years from now) | |
Market Authorisation Date: 07 December, 2012
Treatment: Emergency treatment of allergic reactions (type i), including anaphylaxis; To increase mean arterial blood pressure in adult patients with hypotension associated with septic shock
Dosage: SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS; SOLUTION;INTRAVENOUS
ADRENALIN family patents
3. Auvi-q patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9737669 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US8313466 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US7918823 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US8361029 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US8425462 | KALEO INC | Devices, systems, and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US8608698 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US10737028 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US10314977 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US8920377 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US9056170 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US9833573 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US7731690 | KALEO INC | Devices, systems and methods for medicament delivery |
Jan, 2025
(8 months from now) | |
| US8016788 | KALEO INC | Devices, systems and methods for medicament delivery |
Mar, 2025
(10 months from now) | |
| US10335549 | KALEO INC | Devices, systems and methods for medicament delivery |
Apr, 2025
(1 year, 3 days from now) | |
| US9149579 | KALEO INC | Devices, systems and methods for medicament delivery |
Jul, 2025
(1 year, 2 months from now) | |
| US9259539 | KALEO INC | Devices, systems and methods for medicament delivery |
Feb, 2026
(1 year, 9 months from now) | |
| US9278182 | KALEO INC | Devices, systems and methods for medicament delivery |
Feb, 2026
(1 year, 9 months from now) | |
| US8926594 | KALEO INC | Devices, systems and methods for medicament delivery |
Mar, 2026
(1 year, 11 months from now) | |
| US7731686 | KALEO INC | Devices, systems and methods for medicament delivery |
Jun, 2026
(2 years from now) | |
| US10960155 | KALEO INC | Devices, systems and methods for medicament delivery |
Jun, 2026
(2 years from now) | |
| US11590286 | KALEO INC | Devices, systems and methods for medicament delivery |
Dec, 2026
(2 years from now) | |
| US9238108 | KALEO INC | Medicament delivery device having an electronic circuit system |
Feb, 2027
(2 years from now) | |
| US8206360 | KALEO INC | Devices, systems and methods for medicament delivery |
Feb, 2027
(2 years from now) | |
| US9724471 | KALEO INC | Devices, systems, and methods for medicament delivery |
May, 2027
(3 years from now) | |
| US7947017 | KALEO INC | Devices, systems and methods for medicament delivery |
Mar, 2028
(3 years from now) | |
| US7749194 | KALEO INC | Devices, systems, and methods for medicament delivery |
Oct, 2028
(4 years from now) | |
| US8231573 | KALEO INC | Medicament delivery device having an electronic circuit system |
Nov, 2028
(4 years from now) | |
| US8226610 | KALEO INC | Medical injector with compliance tracking and monitoring |
Apr, 2029
(4 years from now) | |
| US8021344 | KALEO INC | Medicament delivery device configured to produce an audible output |
Nov, 2029
(5 years from now) | |
| US10688244 | KALEO INC | Medicament delivery device and methods for delivering drugs to infants and children |
Dec, 2037
(13 years from now) | |
| US10842938 | KALEO INC | Medicament delivery device and methods for delivering drugs to infants and children |
Dec, 2037
(13 years from now) | |
| US11771830 | KALEO INC | Medicament delivery device and methods for delivering drugs to infants and children |
Dec, 2037
(13 years from now) | |
Market Authorisation Date: 17 November, 2017
Treatment: Method to treat severe allergic emergencies in patients weighing 7.5 to 15 kg (16.5 to 33 lbs); Method of treating allergic reaction via injection; Method for confirming dose delivery; Method of treat...
Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
AUVI-Q family patents
4. Epinephrine patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10004700 | BPI LABS | More potent and less toxic formulations of epinephrine and methods of medical use |
Aug, 2034
(10 years from now) | |
| US10039728 | BPI LABS | More potent and less toxic formulations of epinephrine and methods of medical use |
Aug, 2034
(10 years from now) | |
| US9283197 | BPI LABS | More potent and less toxic formulations of epinephrine and methods of medical use |
Aug, 2034
(10 years from now) | |
Market Authorisation Date: 04 February, 2022
Treatment: Emergency treatment of allergic reactions (type 1), including anaphylaxis; A method of treating allergic reaction, anaphylaxis, anaphylactic shock, or combination thereof by an injection of at least o...
Dosage: SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS
EPINEPHRINE family patents
5. Epipen patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7449012 | MYLAN SPECIALITY LP | Automatic injector |
Sep, 2025
(1 year, 4 months from now) | |
| US7794432 | MYLAN SPECIALITY LP | Automatic injector with kickback attenuation |
Sep, 2025
(1 year, 4 months from now) | |
| US9586010 | MYLAN SPECIALITY LP | Automatic injector with needle cover |
Sep, 2025
(1 year, 4 months from now) | |
| US8048035 | MYLAN SPECIALITY LP | Automatic injector with needle cover |
Sep, 2025
(1 year, 4 months from now) | |
| US8870827 | MYLAN SPECIALITY LP | Automatic injector |
Sep, 2025
(1 year, 4 months from now) | |
Market Authorisation Date: 03 August, 1995
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
EPIPEN family patents
6. Epipen Jr. patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9586010 | MYLAN SPECIALITY LP | Automatic injector with needle cover |
Sep, 2025
(1 year, 4 months from now) | |
| US7449012 | MYLAN SPECIALITY LP | Automatic injector |
Sep, 2025
(1 year, 4 months from now) | |
| US7794432 | MYLAN SPECIALITY LP | Automatic injector with kickback attenuation |
Sep, 2025
(1 year, 4 months from now) | |
| US8870827 | MYLAN SPECIALITY LP | Automatic injector |
Sep, 2025
(1 year, 4 months from now) | |
| US8048035 | MYLAN SPECIALITY LP | Automatic injector with needle cover |
Sep, 2025
(1 year, 4 months from now) | |
Market Authorisation Date: 03 August, 1995
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
EPIPEN JR. family patents
7. Primatene Mist patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8367734 | ARMSTRONG PHARMS | Stable epinephrine suspension formulation with high inhalation delivery efficiency |
Jan, 2026
(1 year, 8 months from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Nov 07, 2021 |
Market Authorisation Date: 07 November, 2018
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
PRIMATENE MIST family patents
8. Symjepi patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11141540 | ADAMIS PHARMS CORP | Syringe devices |
Oct, 2036
(12 years from now) | |
Market Authorisation Date: 27 September, 2018
Treatment: A method for administering a therapeutic dose of epinephrine
Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
SYMJEPI family patents
9. Twinject 0.15 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7297136 | IMPAX | Medicine injection devices and methods |
Jan, 2025
(8 months from now) | |
| US7621891 | IMPAX | Method and apparatus for delivering epinephrine |
Feb, 2025
(9 months from now) | |
Market Authorisation Date: 25 November, 2009
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
TWINJECT 0.15 family patents
10. Twinject 0.3 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7297136 | IMPAX | Medicine injection devices and methods |
Jan, 2025
(8 months from now) | |
| US7621891 | IMPAX | Method and apparatus for delivering epinephrine |
Feb, 2025
(9 months from now) | |
Market Authorisation Date: 25 November, 2009
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
TWINJECT 0.3 family patents